Sonic hedgehog pathway expression in non-small cell lung cancer

by Malvi Savani, Yan Guo, David P. Carbone, Ildiko Csiki
Published 2012-09-01

Long-term Smoking Mediated Down-regulation of Smad3 Induces Resistance to Carboplatin in Non-Small Cell Lung Cancer

by Debangshu Samanta, Jacob Kaufman, David P. Carbone, Pran K. Datta
Published 2012-07-01

Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings

by Mounika U. L. Goruganthu, Anil Shanker, Anil Shanker, Mikhail M. Dikov, David P. Carbone
Published 2020-08-01

ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PATIENTS’ ILLNESS PERCEPTIONS AT DIAGNOSIS

by Stephen B. Lo, Peter G. Shields, David P. Carbone, Carolyn J. Presley, Barbara L. Andersen
Published 2019-06-01

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.

by Amy P Abernethy, Ashwini Arunachalam, Thomas Burke, Caroline McKay, Xiting Cao, Rachael Sorg, David P Carbone
Published 2017-01-01

DLL3: an emerging target in small cell lung cancer

by Dwight H. Owen, Michael J. Giffin, Julie M. Bailis, Marie-Anne Damiette Smit, David P. Carbone, Kai He
Published 2019-06-01

Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma

by Michael F. Sharpnack, Bin Chen, Dvir Aran, Idit Kosti, Douglas D. Sharpnack, David P. Carbone, Parag Mallick, Kun Huang
Published 2018-01-01

Host A2B Adenosine Receptors Promote Carcinoma Growth

by Sergey Ryzhov, Sergey V. Novitskiy, David P. Carbone, Italo Biaggioni, Rinat Zaynagetdinov, Anna E. Goldstein, Mikhail M. Dikov, Igor Feoktistov
Published 2008-09-01

Elucidating the Mechanism of Regulation of Transforming Growth Factor β Type II Receptor Expression in Human Lung Cancer Cell Lines

by Sunil K. Halder, Yong-Jig Cho, Arunima Datta, Govindaraj Anumanthan, Amy-Joan L. Ham, David P. Carbone, Pran K. Datta
Published 2011-10-01

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

by Adrian D. Vickers, Katherine B. Winfree, Gebra Cuyun Carter, Urpo Kiiskinen, Min-Hua Jen, Donald Stull, James A. Kaye, David P. Carbone
Published 2019-04-01

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

by Huabin Hu, Huabin Hu, Longjiang She, Mengting Liao, Yin Shi, Linli Yao, Dong Ding, Youwen Zhu, Shan Zeng, David P. Carbone, Jin Huang
Published 2020-09-01

Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung

by Walter Z. Wang, Konstantin Shilo, Joseph M. Amann, Alyssa Shulman, Mohammad Hojjat-Farsangi, Håkan Mellstedt, Johan Schultz, Carlo M. Croce, David P. Carbone
Published 2021-06-01

Van der Waals pressure and its effect on trapped interlayer molecules

by K. S. Vasu, E. Prestat, J. Abraham, J. Dix, R. J. Kashtiban, J. Beheshtian, J. Sloan, P. Carbone, M. Neek-Amal, S. J. Haigh, A. K. Geim, R. R. Nair
Published 2016-07-01

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database

by Eric D Miller, James L Fisher, Karl E Haglund, John C Grecula, Meng Xu-Welliver, Erin M Bertino, Kai He, Peter G Shields, David P Carbone, Terence M Williams, Gregory A Otterson, Jose G Bazan
Published 2018-10-01

Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency.

by Luiz H Araujo, Cynthia Timmers, Konstantin Shilo, Weiqiang Zhao, Jianying Zhang, Lianbo Yu, Thanemozhi G Natarajan, Clinton J Miller, Ayse Selen Yilmaz, Tom Liu, Joseph Amann, José Roberto Lapa E Silva, Carlos Gil Ferreira, David P Carbone
Published 2015-01-01

Acquired Resistance of EGFR-Mutant Lung Adenocarcinomas to Afatinib plus Cetuximab Is Associated with Activation of mTORC1

by Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, Anna Wurtz, Zenta Walther, Guoping Cai, Zhongming Zhao, Peilin Jia, Elisa de Stanchina, Erik M. Shapiro, Molly Gale, Ruonan Yin, Leora Horn, David P. Carbone, Philip J. Stephens, Vincent Miller, Scott Gettinger, William Pao, Katerina Politi
Published 2014-05-01

AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing

by Georgios I. Laliotis, Evangelia Chavdoula, Maria D. Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A. Nair, Arturo Orlacchio, Vasiliki Taraslia, Ioannis Vlachos, Marina Capece, Artemis Hatzigeorgiou, Dario Palmieri, Christos Tsatsanis, Salvatore Alaimo, Lalit Sehgal, David P. Carbone, Vincenzo Coppola, Philip N. Tsichlis
Published 2021-07-01

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

by Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, Marium Husain, James S. Bassett, Lei Wang, Gabriel Tinoco, Sandip H. Patel, Jarred Burkart, Abdul Miah, Mingjia Li, Andrew Johns, Madison Grogan, David P. Carbone, Claire F. Verschraegen, Kari L. Kendra, Gregory A. Otterson, Lang Li, Carolyn J. Presley, Dwight H. Owen
Published 2020-05-01

Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunity

by Elena E. Tchekneva, Mounika U. L. Goruganthu, Roman V. Uzhachenko, Portia L. Thomas, Anneliese Antonucci, Irina Chekneva, Longzhu Piao, Anwari Akhter, Maria Teresa P. de Aquino, Parvathi Ranganathan, Nicholas Long, Thomas Magliery, Anna Valujskikh, Jason V. Evans, Rajeswara R. Arasada, Pierre P. Massion, David P. Carbone, Mikhail M. Dikov
Published 2019-03-01

Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC

by Daiki Ikarashi, MD, PhD, Tamio Okimoto, MD, PhD, Takehito Shukuya, MD, PhD, Hiroko Onagi, MD, Takuo Hayashi, MD, PhD, Sara L. Sinicropi-Yao, PhD, Joseph M. Amann, PhD, Tetsuya Nakatsura, MD, PhD, Shigehisa Kitano, MD, PhD, David P. Carbone, MD, PhD
Published 2021-10-01